Cowen and Company’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Cowen and Company’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-76,839	Closed	-$139K	–	735
2023 Q2	$139K	Buy	+76,839	New	+$140K	0.01%	229

Other funds holding PRDS

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Cowen and Company's PRDS Position: Q3 2023 in Review

Cowen and Company sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q3 2023, closing a stake of 76,839 shares — an estimated $139K sold.

Cowen and Company first reported a position in PRDS in Q2 2023 and held it in 1 quarter. The position peaked at $139K in Q2 2023. 1 fund tracked by Wall St. Rank holds PRDS as of Q3 2023.

Cowen and Company reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cowen and Company sold 76,839 Pardes Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $139K.
Cowen and Company first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Cowen and Company's Pardes Biosciences, Inc. Common Stock position peaked at $139K in Q2 2023.
1 fund tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q3 2023.

Based on Cowen and Company's 13F filing for Q3 2023, filed 9 Nov 2023.